Dakang Xu

6.3k total citations · 1 hit paper
89 papers, 4.4k citations indexed

About

Dakang Xu is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Dakang Xu has authored 89 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 38 papers in Immunology and 31 papers in Oncology. Recurrent topics in Dakang Xu's work include Immune Cell Function and Interaction (14 papers), Epigenetics and DNA Methylation (11 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Dakang Xu is often cited by papers focused on Immune Cell Function and Interaction (14 papers), Epigenetics and DNA Methylation (11 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Dakang Xu collaborates with scholars based in Australia, China and United States. Dakang Xu's co-authors include Bryan R.G. Williams, Matthew R. Thompson, Xiangliang Yuan, Junping Liu, Peihua Ni, Michael P. Gantier, Kaiyue Wu, Xiaoyan Li, Mark A. Behlke and Die Wang and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Dakang Xu

85 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment

2020 488 citations Xiangliang Yuan, Peihua Ni et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dakang Xu Australia	36	2.3k	1.4k	1.1k	905	437	89	4.4k
Francesca Zazzeroni Italy	35	3.0k 1.3×	1.2k 0.8×	1.6k 1.4×	1.0k 1.1×	289 0.7×	96	5.3k
Xiaojian Wang China	31	1.9k 0.8×	1.5k 1.0×	774 0.7×	929 1.0×	372 0.9×	104	3.8k
Álvaro González Spain	34	1.8k 0.8×	1.6k 1.1×	978 0.9×	1.2k 1.4×	433 1.0×	114	4.6k
Jochen Heß Germany	36	3.2k 1.4×	1.4k 1.0×	1.2k 1.1×	1.4k 1.5×	601 1.4×	125	5.8k
Andrew L. Doedens United States	20	1.6k 0.7×	2.5k 1.8×	1.4k 1.3×	1.0k 1.2×	261 0.6×	24	4.5k
Paola Cappello Italy	38	1.5k 0.7×	1.8k 1.2×	837 0.7×	1.6k 1.8×	295 0.7×	97	4.0k
Latifa Bakiri Austria	37	2.5k 1.1×	699 0.5×	799 0.7×	1.0k 1.1×	342 0.8×	79	4.2k
Stéphane Plaisance Belgium	28	2.8k 1.2×	2.1k 1.4×	1.5k 1.3×	1.2k 1.3×	558 1.3×	48	5.9k
Manfred Kunz Germany	34	2.3k 1.0×	970 0.7×	1.2k 1.1×	806 0.9×	183 0.4×	114	3.8k

Countries citing papers authored by Dakang Xu

Since Specialization

Citations

This map shows the geographic impact of Dakang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dakang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dakang Xu more than expected).

Fields of papers citing papers by Dakang Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dakang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dakang Xu. The network helps show where Dakang Xu may publish in the future.

Co-authorship network of co-authors of Dakang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Dakang Xu. A scholar is included among the top collaborators of Dakang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dakang Xu. Dakang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yuan, Xin, Y. Z. Sun, Lijun Wang, et al.. (2025). Enhancing gastric cancer prognosis prediction via multi-step multi-modality ensemble survival modeling of HE-stained images and mIHC data. Computer Methods and Programs in Biomedicine. 270. 108971–108971.

Yung, Mingo M. H., Xuan Yang, Fushun Chen, et al.. (2024). Polyunsaturated fatty acids promote M2-like TAM deposition via dampening RhoA-YAP1 signaling in the ovarian cancer microenvironment. Experimental Hematology and Oncology. 13(1). 9 indexed citations

Du, Yuzhang, Juanjuan Zheng, Yue Song, et al.. (2022). ATF3 Positively Regulates Antibacterial Immunity by Modulating Macrophage Killing and Migration Functions. Frontiers in Immunology. 13. 839502–839502. 16 indexed citations

Zheng, Juanjuan, Zhongxin Jiang, Yue Song, et al.. (2022). 3,4-Methylenedioxy-β-Nitrostyrene Alleviates Dextran Sulfate Sodium–Induced Mouse Colitis by Inhibiting the NLRP3 Inflammasome. Frontiers in Pharmacology. 13. 866228–866228. 15 indexed citations

Yang, Xiaobao, Yuzhang Du, David W. Chan, et al.. (2021). CXCL8 Associated Dendritic Cell Activation Marker Expression and Recruitment as Indicators of Favorable Outcomes in Colorectal Cancer. Frontiers in Immunology. 12. 667177–667177. 43 indexed citations

Chan, David W., Mingo M. H. Yung, Yau-Sang Chan, et al.. (2020). MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis. Pharmacological Research. 161. 105157–105157. 97 indexed citations

Ying, Le, Feng Yan, Liang Yu, et al.. (2018). PD-L1 expression is a prognostic factor in subgroups of gastric cancer patients stratified according to their levels of CD8 and FOXP3 immune markers. OncoImmunology. 7(6). e1433520–e1433520. 31 indexed citations

Hu, Fanlei, Wei Zhang, Lianjie Shi, et al.. (2018). Impaired CD27+IgD+ B Cells With Altered Gene Signature in Rheumatoid Arthritis. Frontiers in Immunology. 9. 626–626. 31 indexed citations

Cheng, Haibo, Yanan Gao, Bo Zhu, et al.. (2018). β-Elemene Synergizes With Gefitinib to Inhibit Stem-Like Phenotypes and Progression of Lung Cancer via Down-Regulating EZH2. Frontiers in Pharmacology. 9. 1413–1413. 36 indexed citations

10.

Li, Xiaofang, Run Tian, Hugh Gao, et al.. (2017). Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients. Scientific Reports. 7(1). 16495–16495. 53 indexed citations

11.

Xu, Dakang, et al.. (2016). Activating Transcription Factor 3 Expression as a Marker of Response to the Histone Deacetylase Inhibitor Pracinostat. Molecular Cancer Therapeutics. 15(7). 1726–1739. 12 indexed citations

12.

Wang, Tian, Xiaolin Sun, Jing Zhang, et al.. (2014). Regulatory T cells in rheumatoid arthritis showed increased plasticity toward Th17 but retained suppressive function in peripheral blood. Annals of the Rheumatic Diseases. 74(6). 1293–1301. 92 indexed citations

13.

Thompson, Matthew R., Dakang Xu, & Bryan Williams. (2013). Activating Transcription Factor 3 Contributes to Toll-Like Receptor-Mediated Macrophage Survival via Repression of Bax and Bak. Journal of Interferon & Cytokine Research. 33(11). 682–693. 9 indexed citations

14.

Yu, Liang, Junhua Li, Guohua Xie, et al.. (2013). ATF3 Suppresses Metastasis of Bladder Cancer by Regulating Gelsolin-Mediated Remodeling of the Actin Cytoskeleton. Cancer Research. 73(12). 3625–3637. 8 indexed citations

15.

Xu, Dakang, et al.. (2009). Forecasting acute hypotensive episodes in intensive care patients based on a peripheral arterial blood pressure waveform. 545–548. 31 indexed citations

16.

Chen, Lei, Ping Dong, Jian Xue, et al.. (2009). Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner. Clinical Immunology. 134(3). 277–288. 127 indexed citations

17.

Li, He, Dakang Xu, Jinhua Li, Michael C. Berndt, & Junping Liu. (2006). Transforming Growth Factor β Suppresses Human Telomerase Reverse Transcriptase (hTERT) by Smad3 Interactions with c-Myc and the hTERT Gene. Journal of Biological Chemistry. 281(35). 25588–25600. 92 indexed citations

18.

Qi, Sihua, et al.. (2005). Immunological evaluation of combination therapy with tacrolimus and sirolimus on long-term allograft survival in nonhuman primates. Transplantation Proceedings. 37(1). 150–154. 3 indexed citations

19.

Xu, Dakang, Dennis Y. Loh, Pierre Daloze, et al.. (1996). Impaired signaling in alloantigen-specific CD8+ T cells tolerized in vivo: employing a model of Ld-specific TCR transgenic mice transplanted with allogenic hearts under the cover of a short-term rapamycin treatment. The Journal of Immunology. 157(10). 4297–4308. 24 indexed citations

20.

Xu, Dakang, et al.. (1995). Acquired cytomegalovirus infection and blood transfusion in preterm infants. Pediatrics International. 37(4). 444–449. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact